Castle Biosciences, Inc. - Common stock (NQ:CSTL)

33.36 -3.29 (-8.98%)

Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Castle Biosciences, Inc. - Common stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 02, 2023

Via Benzinga

Early Discovery Data Shows Ability of Castle Biosciences’ Pipeline Program to Distinguish Between Responders and Non-Responders to an Atopic Dermatitis Therapy

November 02, 2023

From Castle Biosciences Inc.

Via Business Wire

Castle Biosciences Reports Third Quarter 2023 Results

November 02, 2023

From Castle Biosciences Inc.

Via Business Wire

Castle Biosciences to Present New Data on its TissueCypher® Barrett’s Esophagus Test at the 2023 American College of Gastroenterology Annual Scientific Meeting

October 24, 2023

From Castle Biosciences Inc.

Via Business Wire

Why Castle Biosciences Stock Is Jumping Today ↗

August 03, 2023

The genetic-testing company beat expectations with its Q2 results.

Via The Motley Fool

Castle Biosciences to Release Third Quarter 2023 Financial Results and Host Conference Call on Thursday, Nov. 2

October 19, 2023

From Castle Biosciences Inc.

Via Business Wire

New Data Highlights Clinical Utility and Performance of Castle Biosciences’ Dermatologic Test Portfolio at the 2023 Fall Clinical Dermatology Conference®

October 18, 2023

From Castle Biosciences Inc.

Via Business Wire

DecisionDx®-Melanoma Outperforms Memorial Sloan Kettering Cancer Center (MSKCC) Nomogram in Predicting Sentinel Lymph Node Positivity in Patients with Cutaneous Melanoma

October 05, 2023

From Castle Biosciences Inc.

Via Business Wire

Castle Biosciences's Earnings: A Preview ↗

August 01, 2023

Via Benzinga

Why Shares of Castle Biosciences Fell This Week ↗

July 13, 2023

Reactions to insider selling by two key leaders sent the stock down for a fourth consecutive day.

Via The Motley Fool

Castle Biosciences Presents New Data at ASTRO 2023 Highlighting Risk-Stratification Performance of DecisionDx®-SCC in Patients with Cutaneous Squamous Cell Carcinoma Eligible for Adjuvant Radiation Therapy

October 03, 2023

From Castle Biosciences Inc.

Via Business Wire

Castle Biosciences Shares New Data Demonstrating Ability of TissueCypher® Test Results to Inform Clinical Decision-Making in Patients with Non-Dysplastic Barrett’s Esophagus

October 02, 2023

From Castle Biosciences Inc.

Via Business Wire

Castle Biosciences, Leading Skin Cancer Expert, Darrell Rigel, M.D., M.S., and IMPACT Melanoma Board Member to Ring Nasdaq Closing Bell on Sept. 27, 2023, to Raise Awareness of Melanoma

September 25, 2023

From Castle Biosciences, Inc.

Via Business Wire

Castle Biosciences Ranked Third Among 2023 Top Workplaces in the Healthcare Industry

September 19, 2023

From Castle Biosciences Inc.

Via Business Wire

TissueCypher® Barrett’s Esophagus Test Outperformed Standard of Care in Risk-Stratifying Patients with Barrett’s Esophagus

September 14, 2023

From Castle Biosciences Inc.

Via Business Wire

Castle Biosciences Announces Receipt of New York Laboratory Permit for Pittsburgh Laboratory

September 12, 2023

From Castle Biosciences Inc.

Via Business Wire

Integrating Drug-Drug Interactions and Lifestyle Factors with Drug-Gene Interactions Provided by Castle Biosciences’ IDgenetix® Test Significantly Impacted the Number of Drug Recommendations for Patients with Moderate to Severe Depression

September 09, 2023

From Castle Biosciences Inc.

Via Business Wire

TissueCypher® Provides Clinically-Impactful Risk Stratification in Patients with Barrett’s Esophagus

September 08, 2023

From Castle Biosciences Inc

Via Business Wire

Castle Biosciences to Highlight Clinical Value of IDgenetix® Test at Psych Congress 2023

September 06, 2023

From Castle Biosciences Inc.

Via Business Wire

Castle Biosciences to Participate in Upcoming Investor Conferences

September 05, 2023

From Castle Biosciences Inc.

Via Business Wire

New Publication Highlights the Ability of the TissueCypher® Barrett’s Esophagus Test to Improve and Standardize the Clinical Management of Low-Grade Dysplasia in Patients with Barrett’s Esophagus

August 07, 2023

From Castle Biosciences Inc.

Via Business Wire

Clorox, Boot Barn, Herbalife, Upwork And Other Big Stocks Moving Higher On Thursday ↗

August 03, 2023

U.S. stocks traded lower, with the Dow Jones falling around 100 points on Thursday. Here are some big stocks recording gains in today’s session. Traeger, Inc. (NYSE: COOK) shares jumped 43.2% to $5.90...

Via Benzinga

Castle Biosciences Reports Second Quarter 2023 Results

August 02, 2023

From Castle Biosciences Inc.

Via Business Wire

Castle Biosciences to Present at the Canaccord Genuity 43rd Annual Growth Conference

August 01, 2023

From Castle Biosciences Inc.

Via Business Wire

Bragar Eagel & Squire, P.C. Is Investigating Waldencast, Relmada, DoubleVerify, and Castle and Encourages Investors to Contact the Firm

July 21, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Castle Biosciences to Release Second Quarter 2023 Financial Results and Host Conference Call on Wednesday, Aug. 2

July 19, 2023

From Castle Biosciences Inc.

Via Business Wire

Castle Biosciences to Host Second Annual Castle Cares Charity Walk

July 18, 2023

From Castle Biosciences, Inc.

Via Business Wire

Castle Biosciences Honored as an Arizona Top Workplace for the Second Consecutive Year

July 17, 2023

From Castle Biosciences Inc.

Via Business Wire

Bragar Eagel & Squire, P.C. Is Investigating Castle, Coinbase, Arrival, and BeiGene and Encourages Investors to Contact the Firm

July 16, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 12, 2023

Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.